To start 2017 Liquidmetal Technologies Inc (OTCMKTS:LQMT), ordered its first amorphous metal molding machine from its Licensee, Eontec Co., Ltd. The machine design is based on a die casting platform and is complementary to the injection molding machine developed with Engel. Delivery of the machine was delivered and implemented in March 2017.
A look at the chart below shows the volume start to move along with the price, and a few weeks ago shares made new highs closing up near 35% for the year. We think shares in this company is a subtle investment in the Trump administration’s infrastructure initiative which is fully supported by polls of most Americans, it appears the stock price is starting to capture some of this expectation.
Paul Hauck, Executive Vice President of Sales and Marketing, said: “The machine technology that we are purchasing from Eontec will allow the manufacture of larger parts, up to 300 grams, and will allow us to offer lower cost parts made possible with larger higher-cavitation molds. The machine capabilities from both Eontec and Engel are expected to significantly broaden the number of possible applications across multiple markets. In parallel to this order, our sales team is reviewing past customer opportunities for candidate parts that could be served with the larger capacity machine.”
Liquidmetal Technologies Inc (OTCMKTS:LQMT) announced recently that it has passed additional pre-screening biocompatibility tests for use in medical implants and is now pursuing collaborations with medical implant companies.
Subscribe below and we’ll keep you on top of what’s happening before $LQMT stock makes its next move.
In February of 2017, LQMT received long-term implantation results from parts 3, 10, 6 and 11 of the ISO 10993 (Biological Evaluation of Medical Devices) suite of tests, which include evaluation of genotoxicity, sub-chronic systemic toxicity, and pyrogenicity. LQMT alloy LM105 passed all of these tests well within the allowable limits. These results, combined with previously completed tests from ISO 10993 parts 10, 11, 4, and 5 which cover sensitization, irritation, acute systemic toxicity, hemocompatibility and cytotoxicity, indicate that the Liquidmetal process is compatible with a wide range of medical device requirements including long term implants.
“The results of these tests are very exciting and it positions the Company well to engage medical device customers in a broad range of implantable device applications including, cardiac rhythm, cochlear, spinal, and orthopedic implants among others. The Company will now focus on partnering with medical implant manufacturers to identify specific applications to further explore the use of Liquidmetal,” said Paul Hauck.
As part of the news so far this year the company has fully implemented two hot crucible amorphous metal molding machines from the Company’s licensing partner Eontec Ltd. These Machines allow the production of amorphous alloy parts that are up to three times larger and one-third the cost of established technologies. This technology complements LQMT’s well established cold-crucible systems, which are capable of producing parts that meet requirements for the most demanding medical and automotive applications. The Machines are located in the Company’s new 41,000 square-foot manufacturing facility in Lake Forest, CA., where operations are planned to commence in the second half of this year.
“We are making excellent progress on our plans to significantly expand our market reach and the scale of our operations. Our hot-crucible machines provide the benefits of amorphous alloy technology to price-sensitive applications that were previously beyond our reach,” said Dr. Bruce Bromage, Liquidmetal’s EVP of Business Development and Operations. “I am pleased to be able to join the technology we have developed at Eontec with the exceptional talent and expertise within Liquidmetal,” said Professor Li, Chairman and CEO of Liquidmetal.
Liquidmetal® Technologies, Inc. (OTCMKTS:LQMT) is the leading developer of bulk amorphous alloys. Amorphous alloys are unique materials that are distinguished by their ability to be injection molded and die cast into high performance applications for a broad range of markets.
The share price for molding and liquid metal companies can only be bolstered as companies emerge as infrastructure plays in the new Trump Economy, so this 35% move in the stock price is taking advantage of the expected investment the US Government will make in the economy. Stay here to learn more about companies like these as smaller size market caps grab market share for the upcoming build out. For continuing coverage on shares of $LQMT stock, as well as our other hot stock picks, sign up for our free newsletter today and get our next hot stock pick!